News

HG-CT-1 is the Company's CAR-T therapy, currently undergoing clinical trials in adults for the treatment of R/R AML. This amendment, filed with the U.S. Food and Drug Administration (FDA), seeks ...
Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial. Clinical trial participation can help ...
The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were officially signed into law on 10 April 2025, marking a significant development in the UK clinical trials framework ...
For kidney transplant recipient Janet Handal, the recent push to phase out COVID-19 research could have a deadly outcome. In early 2021, Handal participated in a study that found almost half of ...
Clinical trials allow doctors and researchers to evaluate the effectiveness and safety of various medical treatments. A person with a greater chance of developing a specific condition who meets ...
The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma. Following the results of a hypothesis-generating study of immunotherapy in ...
A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed ...
Spokespeople for Eli Lilly, Bristol Myers Squibb, Sanofi and Roche’s Genentech confirmed in emails to Fierce Biotech that their work on advancing clinical trial diversity remains ongoing.
India's clinical trial share at 8%, compared to China's 29% as of 2022 Regulatory changes and tech investment needed for India Advertising trials could improve patient recruitment in India ...
a biotechnology company focused on the treatment and prevention of cancer announced that it along with its partner Moffitt Cancer Center (Moffitt), has received approval for an amendment to the ...
along with its partner Moffitt Cancer Center ("Moffitt"), has received approval for an amendment to the protocol governing its ongoing clinical trial using CAR-T therapy for the treatment of ...